Percutaneous lung biopsy confirmed adenocarcinoma on November 19, 2018, and he was clinically diagnosed with stage IVa lung adenocarcinoma (cT1cN1M1b) with an EGFR 19del mutation, detected through the Next Generation Sequencing (NGS) platform. This evidence concerns the gene EGFR and lung adenocarcinoma.